Document is current

Any future updates will be listed below

Combined circuit-directed (pre-oxygenator) nafamostat and low-dose systemic unfractionated heparin anticoagulation in ecmo patients with high bleeding risk: A case series and safety evaluation

Crossref DOI link: https://doi.org/10.1007/s11239-026-03293-5

Published Online: 2026-04-29

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark